Male sex and the pattern of recurrent myeloid mutations are strong independent predictors of blood transfusion intensity in patients with myelodysplastic syndromes-Reference-Cited by-同舟云学术

Male sex and the pattern of recurrent myeloid mutations are strong independent predictors of blood transfusion intensity in patients with myelodysplastic syndromes

Published:2018-09-28 Issue:2 Volume:33 Page:522-527
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Rydén Jenny,Edgren Gustaf,Karimi Mohsen,Walldin Gunilla,Tobiasson Magnus,Wikman Agneta,Hellström-Lindberg Eva,Höglund Petter

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0256-0.pdf

Reference15 articles.

1. Cazzola M, Malcovati L. Myelodysplastic syndromes--coping with ineffective hematopoiesis. N Eng J Med. 2005;352:536–8.

2. Zhao J, Ryden J, Wikman A, Norda R, Stanworth SJ, Hjalgrim H. et al. Blood use in hematologic malignancies: a nationwide overview in Sweden between 2000 and 2010. Transfusion. 2018;58:390–401.

3. Ramsey SD, McCune JS, Blough DK, McDermott CL, Beck SJ, Lopez JA, et al. Patterns of blood product use among patients with myelodysplastic syndrome. Vox Sang. 2012;102:331–7.

4. Platzbecker U, Hofbauer LC, Ehninger G, Holig K. The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes. Leuk Res. 2012;36:525–36.

5. de Swart L, Smith A, Johnston TW, Haase D, Droste J, Fenaux P, et al. Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry. Br J Haematol. 2015;170:372–83.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support;Cochrane Database of Systematic Reviews;2024-05-23

2. Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS‐M) prediction in myelodysplastic syndromes;Journal of Internal Medicine;2024-04-23

3. Myelodysplastic syndrome: epidemiology, diagnostics and epigenetic disorders;Medical Herald of the South of Russia;2022-06-16

4. Chemoprotection by Kolaviron ofGarcinia kolain Benzene-induced leukemogenesis in Wistar rats;Egyptian Journal of Basic and Applied Sciences;2022-03-29

5. Management of the Older Patient with Myelodysplastic Syndrome;Drugs & Aging;2021-08-03